Plasma Free Fatty Acid Uptake and Oxidation Are Already Diminished in Subjects at High Risk for Developing Type 2 Diabetes

Diabetes

Volumn 50, Issue 7-12, 2001, Pages 2548-2554

  Mensink, Marco ^a   Blaak, Ellen E ^a   Van Baak, Marleen A ^a   Wagenmakers, Anton J M ^a   Saris, Wim H M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

ADULT; ARTERY; ARTICLE; BLOOD; CARBOHYDRATE METABOLISM; ENERGY METABOLISM; EXERCISE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OSMOLARITY; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; PHYSIOLOGY; RISK FACTOR;

ADULT; ARTERIES; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; EXERCISE; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PREDIABETIC STATE; RISK FACTORS;

EID: 0035514950     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.11.2548     Document Type: Article

References (29)

1. Frayn KN, Williams CM, Arner P: Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? [Editorial] Clin Sci (Colch) 90:243-253, 1996
2. Lewis GF, Vranic M, Harley P, Giacca A: Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46:1111-1119, 1997
3. Hennes MM, Dua A, Kissebah AH: Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46:57-62, 1997
4. Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF: Prolonged elevation of plasma free fatty acids impairs pancreatic β-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49:399-408, 2000
5. Prentki M, Corkey BE: Are the β-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273-283, 1996
6. G. Saloranta C, Groop L: Interactions between glucose and FFA metabolism in man. Diabetes Metab Rev 12:15-35, 1996
7. Colberg SR, Simoneau JA, Thaete FL, Kelley DE: Skeletal muscle utilization of free fatty acids in women with visceral obesity [See comments]. J Clin Invest 95:1840-1853, 1995
8. Kelley DE, Simoneau JA: Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349-2356, 1994
9. Kelley DE, Goodpaster B, Wing RR, Simoneau JA: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130-E1141, 1999
10. Blaak EE, Wagenmakers AJ, Glatz JF, Wolffenbuttel BH, Kemerink GJ, Langenberg CJ, Heidendal GA, Saris WH: Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E140-E154, 2000
11. Blaak EE, van Aggel-Leijssen DPC, Wagenmakers AJM, Saris WHM, van Baak MA: Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49:2102-2107, 2000
12. Falholt K, Jensen I, Lindkaer Jensen S, Mortensen H, Volund A, Heding LG, Noerskov Petersen P, Falholt W: Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabet Med 5:27-31, 1988
13. Standl E, Lotz N, Dexel T, Janka HU, Kolb HJ: Muscle triglycerides in diabetic subjects: effect of insulin deficiency and exercise. Diabetologia 18:463-469, 1980
14. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Haring HU: Association of increased intramyorellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113-1119, 1999
15. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988, 1997
16. Alberti KG: The clinical implications of impaired glucose tolerance. Diabet Med 13:927-937, 1996
17. Siri W: The gross composition of the body. Adv Biol Med Physiol 4:239-280, 1956
18. Wagenmakers AJ, Rehrer NJ, Brouns F, Saris WH, Halliday D: Breath 13CO2 background enrichment during exercise: diet-related differences between Europe and America. J Appl Physiol 74:2353-2357, 1993
19. Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR: A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol 269:E649-E656, 1995
20. Weir J: New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol (London) 109:1-9, 1949
21. Frayn KN: Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628-634, 1983
22. 13C]substrate oxidation. Clin Sci (Colch) 98:587-592, 2000
23. Sial S, Coggan AR, Hickner RC, Klein S: Training-induced alterations in fat and carbohydrate metabolism during exercise in elderly subjects. Am J Physiol 274:E785-E790, 1998
24. Blaak EE: Adrenergically stimulated fat utilization and ageing. Ann Med 32:380-382, 2000
25. Kang J, Kelley DE, Robertson RJ, Goss FL, Suminski RR, Utter AC, Dasilva SG: Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Med Sci Sports Exerc 31:82-89, 1999
26. Colberg SR, Hagberg JM, McCole SD, Zmuda JM, Thompson PD, Kelley DE: Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise. J Appl Physiol 81:2027-2033, 1996
27. Jansson PA, Smith U, Lonnroth P: Microdialysis assessment of adipose tissue metabolism in post-absorptive obese NIDDM subjects. Eur J Clin Invest 25:584-589, 1995
28. Eriksson J, Lindstrom J, Valle T, Aunola S, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, Lehtonen A, Louheranta A, Mannelin M, Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J: Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 42:793-801, 1999
29. Schmitz-Peiffer C: Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12:583-594, 2000